Paradigm Biocapital Advisors LP Portfolio Holdings

Paradigm Biocapital Advisors LP

  • $2.77 Billion
  • Q3 2024

Paradigm Biocapital Advisors LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $2.77 Billion distributed in 33 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Nuvalent, Inc. with a value of $512M, Arcellx, Inc. with a value of $334M, Argenx Se with a value of $261M, Revolution Medicines, Inc. with a value of $241M, and Crinetics Pharmaceuticals, Inc. with a value of $129M.

Examining the 13F form we can see an increase of $304M in the current position value, from $2.47B to 2.77B.

Paradigm Biocapital Advisors LP is based out at New York, NY

Below you can find more details about Paradigm Biocapital Advisors LP portfolio as well as his latest detailed transactions.

Portfolio value $2.77 Billion
Healthcare: $2.77 Billion

Stock Holdings Table Companies Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$4.08B
$512 Million 18.43% of portfolio
5,000,000
Q3 2024 Added 9.37%
$3.86B
$334 Million 12.04% of portfolio
4,000,000
Q3 2024 Added 3.95%
$33.5B
$261 Million 9.39% of portfolio
480,374
Q3 2024 Reduced 10.73%
$4.98B
$241 Million 8.68% of portfolio
5,314,089
Q3 2024 Added 1.05%
$3.01B
$129 Million 4.63% of portfolio
2,516,686
Q3 2024 Added 0.13%
$2.09B
$123 Million 4.42% of portfolio
2,454,917
Q3 2024 Added 21.54%
$1.94B
$109 Million 3.93% of portfolio
2,400,574
Q3 2024 Added 53.45%
$722M
$84.6 Million 3.05% of portfolio
4,331,321
Q3 2024 Reduced 4.58%
$1.24B
$80.3 Million 2.89% of portfolio
2,440,445
Q3 2024 Added 0.21%
$2.02B
$74.4 Million 2.68% of portfolio
2,789,172
Q3 2024 Added 19.94%
$5.25B
$71.7 Million 2.58% of portfolio
627,732
Q3 2024 Added 0.08%
$783M
$65.9 Million 2.37% of portfolio
2,895,689
Q3 2024 Reduced 0.02%
$318M
$65.7 Million 2.37% of portfolio
5,503,600
Q3 2024 Reduced 30.37%
$1.38B
$57.6 Million 2.08% of portfolio
2,339,961
Q3 2024 Reduced 4.03%
$455M
$53.7 Million 1.93% of portfolio
4,086,346
Q3 2024 Added 5.57%
$591M
$49.8 Million 1.79% of portfolio
4,609,762
Q3 2024 Added 27.19%
$1.92B
$47 Million 1.69% of portfolio
931,480
Q3 2024 New
$19.8B
$45 Million 1.62% of portfolio
200,336
Q3 2024 New
$578M
$44.6 Million 1.61% of portfolio
3,904,862
Q3 2024 Added 14.11%
$557M
$38.9 Million 1.4% of portfolio
2,321,013
Q3 2024 Added 50.44%
$3.55B
$37.5 Million 1.35% of portfolio
1,362,827
Q2 2024 Added 70.56%
$626M
$34.8 Million 1.25% of portfolio
3,104,486
Q3 2024 New
$1.44B
$30.5 Million 1.1% of portfolio
525,037
Q3 2024 New
$330M
$29.1 Million 1.05% of portfolio
10,668,141
Q3 2024 Added 47.15%
$363M
$9.91 Million 0.36% of portfolio
1,160,000
Q3 2024 Reduced 50.34%

Summary

  • Portfolio
  • No. of Stocks 33
  • Current Value $2.77 Billion
  • Prior Value $2.47 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 7 stocks
  • Additional Purchases 15 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 7 stocks
Track This Portfolio

Track Paradigm Biocapital Advisors LP Portfolio

Follow Paradigm Biocapital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Biocapital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Biocapital Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email